No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1118 |
4. Check minimum number of eventsNone |
1118 |
5. Include endpointsNone |
1118 |
6. Filter based on genotype QC (FinnGen only) |
1088 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Hypogonadotropic hypogonadism
based on the number of shared cases.
Similar with more cases:
- Hypopituitarism
- Exclusions for E4_PCOS_BROAD
- Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT
- Disorders of other endocrine glands
- Exclusions for E4_PCOS_CONSORTIUM
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1088 | 73 | 1015 |
| Unadjusted period prevalence (%) | 0.44 | 0.03 | 0.47 |
| Median age at first event (years) | 48.86 | 31.20 | 50.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1118
- Matched controls
- 11180
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
101
Kela drug reimbursment
Anterior pituitary hypofunction
228.3
307.7
347
22
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
4503599627370496.0
307.7
1116
59
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
83.9
307.7
217
32
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
91.7
307.7
905
495
E29.1
ICD-10 Finland
Testicular hypofunction
14.8
202.6
193
155
Y28
ICPC
Limited function/disability (Y)
36.1
175.2
111
34
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
15.2
168.8
156
118
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
39.4
168.4
104
29
121
Kela drug reimbursment
Severe hypofunction of sexual glands
17.8
114.4
95
58
G47.3
ICD-10 Finland
Sleep apnoea
3.8
106.6
540
2188
T99
ICPC
Endocr/metab/nutrit disease other
16.9
104.5
89
57
H02AB09
ATC
hydrocortisone; systemic
13.1
103.3
102
85
A55
ICPC
General and Unspecified, Local injection/infiltration
12.9
92.8
92
77
H03AA01
ATC
levothyroxine sodium; systemic
4.5
87.3
256
693
N04BC06
ATC
cabergoline; oral
41.9
85.9
52
13
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
46.5
82.9
49
11
G03GA01
ATC
chorionic gonadotrophin; parenteral
18.3
78.8
64
37
A50
ICPC
General and Unspecified, Medication/prescr/renewal
7.2
77.0
121
185
N06AX16
ATC
venlafaxine; oral
3.8
72.6
270
860
WVA30, ,
SPAT
6.0
71.6
136
252
E23.00
ICD-10 Finland
Panhypopituitarism
90.5
61.7
68
8
N06AX26
ATC
vortioxetine; oral
4.3
60.2
174
459
E22.1
ICD-10 Finland
Hyperprolactinaemia
86.3
58.6
65
8
N06AX21
ATC
duloxetine; oral
3.9
58.5
202
605
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.7
58.2
509
2613
N06AX11
ATC
mirtazapine; oral
2.7
57.1
468
2321
T28
ICPC
Limited function/disability (T)
16.7
56.7
48
30
E66.01
ICD-10 Finland
Obesity due to excess calories
4.1
56.0
170
464
R5140
NOMESCO Finland
Monitoring the use of the aid
3.3
53.9
240
846
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.2
50.7
236
852
N05AH04
ATC
quetiapine; oral
2.9
50.6
321
1380
N06AB10
ATC
escitalopram; oral
2.8
48.4
324
1429
E66.8
ICD-10 Finland
Other obesity
4.9
47.2
111
247
E29.9
ICD-10 Finland
Testicular dysfunction, unspecified
16.6
47.1
40
25
N05BA04
ATC
oxazepam; oral
2.7
46.4
316
1402
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
4.5
43.6
114
276
N06AX12
ATC
bupropion; oral
3.5
42.9
170
552
R53
ICD-10 Finland
Malaise and fatigue
2.7
42.2
294
1312
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.4
41.6
111
273
N03AX16
ATC
[U] pregabalin
2.6
41.1
298
1354
E66.00
ICD-10 Finland
Metabolic syndrome
4.1
40.4
120
320
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.7
38.5
134
399
N03AX09
ATC
lamotrigine; oral
4.1
37.6
112
299
E23.05
ICD-10 Finland
Lack of TSH
85.1
37.0
41
5
N03AE01
ATC
clonazepam; systemic
4.0
36.1
108
289
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.5
35.9
134
417
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
127.4
34.9
37
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.7
34.2
209
864
N05CF01
ATC
zopiclone; oral
2.3
34.2
351
1848
N03AX12
ATC
[U] gabapentin; oral
2.7
34.0
216
911
N05CF02
ATC
zolpidem; oral
2.6
33.4
228
996
Y08
ICPC
Sexual function sympt/compl male
12.6
33.4
33
27
N06AB04
ATC
citalopram; systemic
2.5
32.6
246
1126
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
8.8
32.4
41
48
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
87.7
30.9
34
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
30.2
284
1430
N02AX02
ATC
tramadol; systemic, rectal
2.1
30.2
509
3221
N05BA12
ATC
alprazolam; oral
3.0
28.9
142
520
N06AX22
ATC
agomelatine; oral
5.3
28.8
59
116
N06AB06
ATC
sertraline; oral
2.8
28.6
165
659
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.0
28.5
139
507
N48.4
ICD-10 Finland
Impotence of organic origin
4.0
28.5
84
222
N91.1
ICD-10 Finland
Secondary amenorrhoea
31.8
28.3
37
12
L02BG04
ATC
letrozole; oral
7.4
28.1
41
57
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.3
27.3
73
179
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.8
27.3
86
238
-50
ICPC
Medication/prescr/renewal
4.7
27.1
64
142
I10
ICD-10 Finland
Essential (primary) hypertension
2.0
26.7
587
4021
N62
ICD-10 Finland
Hypertrophy of breast
6.2
26.5
46
77
SPAT1254
SPAT
Administration of medicine
2.7
26.1
156
633
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.9
26.0
80
218
N05BA01
ATC
diazepam; systemic, rectal
2.6
25.2
166
706
T29
ICPC
Endocr/metab/nutr sympt/compl other
6.8
25.2
40
61
M03BX02
ATC
tizanidine; oral
2.0
25.1
741
5562
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
24.9
267
1406
L03
ICPC
Low back symptom/complaint
2.1
24.4
302
1680
C07AA05
ATC
propranolol; systemic
2.2
24.3
242
1237
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
24.2
208
999
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
23.9
246
1273
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
23.7
114
411
M01AE02
ATC
naproxen; oral, rectal
1.9
23.6
633
4561
N05CD07
ATC
temazepam; oral
3.0
22.9
110
396
R51.80
ICD-10 Finland
Headache
2.4
22.7
185
866
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
22.6
223
1132
N06AA09
ATC
amitriptyline; systemic
3.1
22.5
97
328
M54.5
ICD-10 Finland
Low back pain
1.9
22.5
421
2692
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
22.2
532
3673
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
22.2
159
702
A02BC05
ATC
esomeprazole; systemic
1.9
22.2
423
2717
N02BF02
ATC
pregabalin; oral
3.3
22.2
86
273
A02BC02
ATC
pantoprazole; systemic
1.9
22.0
697
5245
N06AB03
ATC
fluoxetine; oral
2.6
21.7
141
594
R06.0
ICD-10 Finland
Dyspnoea
2.1
21.4
252
1368
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
21.4
148
643
WX723
NOMESCO Finland
CPAP therapy
3.1
21.1
92
313
N02BE01
ATC
paracetamol; systemic, rectal
2.2
21.0
948
7975
G03FB08
ATC
dydrogesterone and estrogen; systemic
18.3
20.9
32
18
L02BG03
ATC
anastrozole; oral
38.0
20.8
26
7
P76
ICPC
Depressive disorder
2.9
20.6
100
362
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
20.6
274
1553
N06AB05
ATC
paroxetine; oral
3.1
20.5
91
313
P19
ICPC
Drug abuse
5.9
20.3
37
65
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.4
20.1
76
237
D75.1
ICD-10 Finland
Secondary polycythaemia
7.7
20.0
28
37
SPAT1310
SPAT
Counselling related to known health issue
1.9
19.8
313
1877
R03AC02
ATC
salbutamol; inhalant
1.8
19.8
568
4095
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.6
19.8
127
532
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
19.6
204
1054
M01AH05
ATC
etoricoxib; oral
1.8
19.5
723
5608
N05BE01
ATC
buspirone; oral
3.7
19.4
62
173
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
19.4
183
908
J01AA02
ATC
doxycycline; systemic
1.9
19.4
798
6387
XCK00
NOMESCO Finland
Perimetry
3.8
19.4
60
164
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.5
19.3
48
111
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
19.3
112
446
M79.6
ICD-10 Finland
Pain in limb
1.8
19.3
427
2846
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.8
19.2
30
45
A10BA02
ATC
metformin; oral
1.9
19.2
288
1697
N02AA05
ATC
oxycodone; systemic
2.3
19.0
158
744
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
18.8
515
3643
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
18.7
471
3251
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
8.0
18.3
25
32
A10BJ02
ATC
liraglutide; parenteral
4.2
18.2
49
121
R06.5
ICD-10 Finland
Mouth breathing
2.3
18.1
159
765
F60.5
ICD-10 Finland
Anankastic personality disorder
7.1
17.9
27
39
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
17.6
365
2370
R01AD12
ATC
fluticasone furoate; nasal
1.8
17.6
361
2337
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.1
17.3
196
1041
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.1
17.1
74
251
M48.0
ICD-10 Finland
Spinal stenosis
2.6
17.1
105
430
SPAT1216
SPAT
Assessment of functional ability
2.5
17.1
115
492
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.0
16.9
230
1303
C09CA06
ATC
candesartan; oral
1.9
16.9
251
1465
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
16.9
138
644
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4.3
16.8
44
106
P06
ICPC
Sleep disturbance
2.2
16.8
156
767
N06BA04
ATC
methylphenidate; oral
3.2
16.6
69
228
N06AG02
ATC
moclobemide; oral
3.4
16.6
60
182
R52.2
ICD-10 Finland
Other chronic pain
3.7
16.6
53
148
C07AB07
ATC
bisoprolol; oral
1.7
16.6
418
2862
WZC00
NOMESCO Finland
Treatment plan or consultation
1.8
16.5
370
2449
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.5
16.5
40
91
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
16.2
97
392
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
16.1
291
1807
G44.2
ICD-10 Finland
Tension-type headache
2.3
15.7
132
622
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
15.6
272
1668
WX722
NOMESCO Finland
PEEP
2.9
15.5
74
265
Y29
ICPC
Genital symptom/complaint male other
5.8
15.4
28
49
F32.1
ICD-10 Finland
Moderate depressive episode
2.7
15.3
86
336
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
7.1
15.3
23
33
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
45.7
15.1
18
*
J01DB01
ATC
cefalexin; oral
1.9
15.1
916
7882
L01
ICPC
Neck symptom/complaint
2.1
15.0
151
765
M81.9
ICD-10 Finland
Osteoporosis, unspecified
5.9
15.0
27
47
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
15.0
443
3146
A02BC03
ATC
lansoprazole; oral
1.8
15.0
253
1534
G02CB03
ATC
cabergoline; oral
57.5
14.8
17
*
SPAT1229
SPAT
Assessment of need for aid
3.2
14.8
60
196
C08CA01
ATC
amlodipine; oral
1.7
14.7
338
2241
M54.2
ICD-10 Finland
Cervicalgia
2.4
14.7
104
455
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
14.6
179
975
F31.8
ICD-10 Finland
Other bipolar affective disorders
4.0
14.6
42
109
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
14.6
267
1657
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
14.6
291
1853
N46
ICD-10 Finland
Male infertility
3.3
14.5
56
177
J01FA10
ATC
azithromycin; systemic
1.6
14.4
615
4777
R01AD09
ATC
mometasone; nasal
1.6
14.4
474
3450
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.2
14.3
135
666
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.8
14.3
71
260
L08
ICPC
Shoulder symptom/complaint
1.9
14.3
215
1254
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
27.6
14.3
19
7
SPAT1240
SPAT
Therapeutic discussion
2.2
14.3
133
654
N06AA12
ATC
doxepin; systemic
3.3
14.1
55
175
G03DB01
ATC
dydrogesterone; oral
4.4
14.1
35
81
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
12.1
14.1
25
21
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
14.1
270
1696
SPAT1312
SPAT
General health counselling
1.7
14.0
292
1880
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.0
14.0
63
219
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.0
14.0
63
219
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
4.0
13.9
40
104
H01AC01
ATC
somatropin; parenteral
17.8
13.9
21
12
E03.89
ICD-10 Finland
Other specified hypothyroidism
4.7
13.8
32
70
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.2
13.8
122
587
N06AX03
ATC
mianserin; oral
3.2
13.7
55
178
SPAT1262
SPAT
Handing over of treatment supplies
2.0
13.7
177
980
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
13.7
282
1808
F34.1
ICD-10 Finland
Dysthymia
3.2
13.7
56
184
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.0
13.6
39
101
L17
ICPC
Foot/toe symptom/complaint
1.8
13.5
252
1568
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.2
13.4
118
566
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
13.3
181
1020
XKD00
NOMESCO Finland
Uroflowmetry
1.9
13.3
175
976
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.6
13.2
77
307
M79.1
ICD-10 Finland
Myalgia
2.0
13.2
148
780
E23.03
ICD-10 Finland
Lack of ACTH
40.6
13.2
16
*
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
13.2
748
6171
SFA10
NOMESCO Finland
One-surface restoration
1.6
13.2
617
4859
SPAT1301
SPAT
No procedures
1.7
13.1
267
1705
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
13.1
343
2344
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.9
13.0
38
100
J01FF01
ATC
clindamycin; systemic
1.7
12.9
288
1882
P03
ICPC
Feeling depressed
2.2
12.9
115
554
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.6
12.9
625
4949
Z01.2
ICD-10 Finland
Dental examination
1.6
12.9
475
3527
WX780
NOMESCO Finland
Remote monitoring CPAP
2.5
12.8
82
342
T90
ICPC
Diabetes non-insulin dependent
1.8
12.7
228
1400
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
5.0
12.7
27
55
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
12.7
811
6858
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
12.6
253
1606
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
12.5
340
2340
N03AG01
ATC
valproic acid; systemic, rectal
2.4
12.4
88
385
SPAT1377
SPAT
Polysomnography
3.1
12.4
51
168
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
3.2
12.4
50
163
T82
ICPC
Obesity
3.1
12.4
53
179
Y99
ICPC
Genital disease male other
14.5
12.3
20
14
N06AX05
ATC
trazodone; oral
3.7
12.2
39
109
S18
ICPC
Laceration/cut
1.6
12.2
431
3158
N04BC05
ATC
pramipexole; oral
2.6
12.2
70
277
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.5
12.2
41
119
C08CA13
ATC
lercanidipine; oral
2.1
12.0
116
578
A04
ICPC
Weakness/tiredness general
2.1
12.0
121
613
ZXC86
NOMESCO Finland
Use of endoscopic device
13.6
12.0
20
15
301
Kela drug reimbursment
Growth hormone
47.2
11.9
14
*
F32
ICD-10 Finland
Depressive episode
2.6
11.8
72
293
N06AX18
ATC
reboxetine; oral
5.9
11.8
21
36
R4110, ,
SPAT
2.5
11.8
74
306
L28
ICPC
Limited function/disability (L)
2.1
11.7
116
583
R01AD58
ATC
fluticasone, combinations; nasal
1.7
11.7
276
1826
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
11.7
784
6630
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
4.2
11.6
31
76
R03BA05
ATC
fluticasone; inhalant
1.9
11.6
169
971
G04CA01
ATC
alfuzosin; oral
1.8
11.6
188
1117
AA1AD
NOMESCO Finland
CT of head and brain
1.7
11.6
235
1491
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
11.6
191
1141
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
11.6
228
1435
R42
ICD-10 Finland
Dizziness and giddiness
1.9
11.6
171
988
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.9
11.5
161
913
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
11.4
445
3324
G03GA02
ATC
human menopausal gonadotrophin; parenteral
12.0
11.4
20
17
M05BA04
ATC
alendronic acid; oral
3.5
11.3
39
115
N05AX12
ATC
aripiprazole; systemic
2.4
11.3
77
331
E23.06
ICD-10 Finland
Empty sella
35.4
11.3
14
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.4
11.2
80
351
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.5
11.2
70
289
SPAT1263
SPAT
Sampling
1.6
11.2
384
2782
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
11.2
517
4005
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.4
11.1
77
333
TAB00
NOMESCO Finland
Lumbar puncture
2.8
11.1
56
207
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.1
11.1
45
147
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
11.1
265
1756
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.6
11.1
66
266
L15
ICPC
Knee symptom/complaint
1.8
11.1
196
1196
A29
ICPC
General symptom/complaint other
2.1
11.1
107
533
A10BJ06
ATC
semaglutide; parenteral
2.5
11.0
71
297
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
11.0
114
582
UKC02
NOMESCO Finland
Cystoscopy
1.9
11.0
140
769
J05AB01
ATC
aciclovir; systemic
1.8
11.0
177
1049
M01AH01
ATC
celecoxib; oral
1.9
11.0
146
814
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
11.0
207
1286
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
43.8
10.9
13
*
T55
ICPC
Metabolic, Local injection/infiltration
12.1
10.9
19
16
F90.0
ICD-10 Finland
Disturbance of activity and attention
2.6
10.8
65
264
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.1
10.7
106
533
C07AB12
ATC
nebivolol; oral
3.2
10.6
41
130
A02BC01
ATC
omeprazole; systemic
1.7
10.6
215
1361
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
10.6
426
3187
M25.5
ICD-10 Finland
Pain in joint
1.6
10.6
317
2217
SPAT1360
SPAT
Extensive global examination
2.7
10.6
59
230
R05FB02
ATC
cough suppressants and expectorants; systemic
1.6
10.6
296
2037
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.0
10.6
124
663
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
10.5
150
856
WX290
NOMESCO Finland
Other blockage of nerve
1.5
10.5
577
4617
M02AA07
ATC
piroxicam; topical
1.6
10.5
296
2043
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.7
10.4
236
1542
E03
ICD-10 Finland
Other hypothyroidism
3.3
10.3
39
122
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
10.3
254
1692
E30.09
ICD-10 Finland
Delayed puberty NOS
23.6
10.3
14
6
H04.10
ICD-10 Finland
Dry eye syndrome
2.2
10.2
92
446
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.7
10.2
246
1631
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
10.1
100
502
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.1
10.1
102
516
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.8
10.1
30
80
P01
ICPC
Feeling anxious/nervous/tense
1.9
10.1
128
703
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
4.9
10.0
22
46
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.7
10.0
31
85
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.0
10.0
44
151
M01AB05
ATC
diclofenac; systemic, rectal
1.5
10.0
718
6047
N06AA10
ATC
nortriptyline; systemic
3.9
10.0
29
76
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
40.4
10.0
12
*
J01MA02
ATC
ciprofloxacin; systemic
1.5
10.0
362
2642
A06AD11
ATC
lactulose; oral
2.1
10.0
100
505
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.5
9.9
62
256
C10AA07
ATC
rosuvastatin; oral
1.6
9.9
308
2169
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.3
9.9
79
364
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
2.1
9.9
94
465
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
16.9
9.9
15
9
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.4
9.9
65
275
F51.0
ICD-10 Finland
Nonorganic insomnia
1.8
9.8
177
1083
T83
ICPC
Overweight
4.4
9.8
24
55
R03DC03
ATC
montelukast; oral
1.8
9.8
151
882
J01CA04
ATC
amoxicillin; systemic
1.6
9.8
870
7660
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
9.7
109
573
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.6
9.7
300
2109
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.4
9.7
67
290
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
55.5
9.7
11
*
3051, ,
Kela drug reimbursment
5.4
9.7
19
36
J02AC01
ATC
fluconazole; systemic
1.7
9.7
219
1427
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
9.6
289
2017
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
9.6
563
4531
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.8
9.6
48
177
R03BA08
ATC
ciclesonide; inhalant
2.2
9.5
84
404
R01AD08
ATC
fluticasone; nasal
1.6
9.5
289
2023
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.1
9.5
90
445
SPAT1153
SPAT
Removal of sutures
1.6
9.5
262
1793
N02BF01
ATC
gabapentin; oral
2.2
9.4
81
385
R04
ICPC
Breathing problem other
2.9
9.4
42
146
R06AE07
ATC
cetirizine; oral
1.5
9.3
408
3089
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
9.3
99
511
R02
ICPC
Shortness of breath/dyspnoea
2.0
9.2
98
505
N05AN01
ATC
lithium; oral
2.9
9.2
43
153
T50
ICPC
Metabolic, Medication/prescr/renewal
13.8
9.2
15
11
A46
ICD-10 Finland
Erysipelas
1.8
9.2
155
930
C09CA01
ATC
losartan; oral
1.6
9.2
222
1469
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
9.2
310
2220
C10AC01
ATC
colestyramine; oral
3.5
9.1
31
91
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
9.1
41
143
ZX114
NOMESCO Finland
Intramuscular
4.6
9.1
21
46
R03BA02
ATC
budesonide; inhalant
1.8
9.1
155
934
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
10.1
9.0
17
17
Z00.0
ICD-10 Finland
General medical examination
1.7
9.0
180
1132
102
Kela drug reimbursment
Diabetes insipidus
37.0
9.0
11
*
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.2
9.0
76
359
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
18.8
8.9
13
7
H02AB06
ATC
prednisolone; systemic
1.5
8.9
433
3341
R60.0
ICD-10 Finland
Localized oedema
2.0
8.9
95
491
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
8.9
233
1572
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
12.7
8.9
15
12
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
9.6
8.8
17
18
A10BH01
ATC
sitagliptin; oral
2.1
8.8
85
424
R29
ICPC
Respiratory symptom/complaint other
2.2
8.7
70
324
R52.1
ICD-10 Finland
Chronic intractable pain
6.7
8.7
21
32
C10AA05
ATC
atorvastatin; oral
1.5
8.7
363
2715
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
7.7
8.7
19
25
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.5
8.7
52
211
N06AB08
ATC
fluvoxamine; oral
3.1
8.6
36
120
G03GA05
ATC
follitropin alfa; parenteral
8.3
8.6
18
22
R86.1
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of hormones
11.7
8.6
15
13
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.8
8.6
41
148
J45
ICD-10 Finland
Asthma
2.0
8.5
90
463
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.2
8.5
71
334
E23.2
ICD-10 Finland
Diabetes insipidus
20.2
8.5
12
6
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
8.5
76
368
J34.2
ICD-10 Finland
Deviated nasal septum
2.0
8.4
98
522
S29
ICPC
Skin symptom/complaint other
1.7
8.4
155
953
E66
ICD-10 Finland
Obesity
2.3
8.4
63
283
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.5
8.4
50
202
J01CF05
ATC
flucloxacillin; systemic
2.1
8.4
76
369
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.2
8.4
32
101
P20
ICPC
Memory disturbance
2.4
8.4
59
258
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.4
8.4
570
4677
Z51.80
ICD-10 Finland
Manipulation of puberty development with hormone therapy
+∞
8.3
8
*
C03CA01
ATC
furosemide; systemic
1.7
8.3
159
987
J02AC02
ATC
itraconazole; systemic
1.8
8.3
142
854
SCA01
NOMESCO Finland
Preventive oral health care, short
1.5
8.3
289
2076
N97.0
ICD-10 Finland
Female infertility associated with anovulation
10.8
8.3
15
14
A98
ICPC
Health maint/preventive medicine
2.9
8.3
1087
10338
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
9.5
8.3
16
17
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
8.3
202
1337
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
8.3
212
1421
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
8.2
242
1674
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.7
8.2
43
163
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
6.5
8.2
20
31
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.1
8.2
82
414
D82
ICPC
Teeth/gum disease
1.5
8.2
392
3005
WZA90
NOMESCO Finland
Other medical or dental certificate
1.6
8.2
235
1618
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.8
8.1
39
141
160
Kela drug reimbursment
exenatide
3.4
8.1
28
83
C05AA08
ATC
fluocortolone; rectal, topical
1.8
8.1
122
707
H53.4
ICD-10 Finland
Visual field defects
4.1
8.1
22
55
R03AK08
ATC
formoterol and beclometasone; inhalant
2.7
8.0
43
165
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.2
8.0
21
51
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.6
8.0
45
177
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
3.9
8.0
23
60
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
3.9
8.0
23
60
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
7.3
8.0
18
25
N06AA06
ATC
trimipramine; systemic
3.3
8.0
29
89
N05AA02
ATC
levomepromazine; systemic
2.3
7.9
57
252
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.5
7.8
26
75
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.6
7.8
191
1264
C03AA03
ATC
hydrochlorothiazide; oral
2.4
7.8
52
222
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.3
7.8
55
241
A10BX09
ATC
[U] dapagliflozin
7.0
7.8
18
26
A99
ICPC
Disease/condition unspecnature/site
2.0
7.8
82
422
J01FA09
ATC
clarithromycin; systemic
1.5
7.8
295
2155
XG466
NOMESCO Finland
Sleep oxymetry
2.6
7.7
44
174
N40
ICD-10 Finland
Hyperplasia of prostate
1.6
7.7
210
1425
SFA20
NOMESCO Finland
Two-surface restoration
1.4
7.7
649
5499
N91.0
ICD-10 Finland
Primary amenorrhoea
45.3
7.7
9
*
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
7.6
257
1829
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
3.1
7.6
31
102
ZX120
NOMESCO Finland
Intravenous
2.0
7.6
80
412
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.8
7.6
122
722
N29
ICPC
Neurological sympt/complt other
4.1
7.6
20
49
G03GA06
ATC
follitropin beta; parenteral
8.9
7.6
15
17
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
7.6
73
364
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
7.5
121
715
L86
ICPC
Back syndrome with radiating pain
2.3
7.4
56
253
OAB72
NOMESCO Finland
Weight control and weight loss guidance
6.0
7.4
19
32
G62.8
ICD-10 Finland
Other specified polyneuropathies
6.0
7.4
19
32
D07AD01
ATC
clobetasol; topical
1.7
7.4
141
875
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
4.1
7.4
20
50
F41.00
ICD-10 Finland
Moderate panic disorder
3.5
7.3
24
69
CS494
NOMESCO Finland
Other visual field testing
3.4
7.3
25
74
UJF32
NOMESCO Finland
Coloscopy
1.6
7.3
206
1410
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.5
7.3
46
192
M81.5
ICD-10 Finland
Idiopathic osteoporosis
15.9
7.2
11
7
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.9
7.2
94
521
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
7.2
536
4424
A07AA02
ATC
nystatin; oral
2.7
7.2
38
145
K02.1
ICD-10 Finland
Caries of dentine
1.4
7.2
663
5680
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
3.2
7.1
27
85
DJD20
NOMESCO Finland
Plastic repair of septum of nose
2.1
7.1
70
351
Z31.5
ICD-10 Finland
Genetic counselling
2.4
7.1
47
200
P01AB01
ATC
metronidazole; oral, rectal
1.5
7.1
303
2260
Y50
ICPC
Male Genital, Medication/prescr/renewal
12.1
7.1
12
10
M80.5
ICD-10 Finland
Idiopathic osteoporosis with pathological fracture
12.1
7.1
12
10
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.2
7.1
61
291
205
Kela drug reimbursment
Chronic hypertension
1.6
7.1
163
1062
S01GX01
ATC
cromoglicic acid; ophthalmic
1.6
7.1
167
1095
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
7.1
81
430
M01AC06
ATC
meloxicam; systemic, rectal
1.5
7.1
308
2307
Z3231
NOMESCO Finland
Registered nurse
1.5
7.0
240
1711
R25.1
ICD-10 Finland
Tremor, unspecified
3.2
7.0
27
86
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.4
7.0
330
2507
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
7.0
7.0
16
23
F31
ICD-10 Finland
Bipolar affective disorder
3.4
7.0
24
71
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
7.0
70
354
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
7.0
239
1704
F45.8
ICD-10 Finland
Other somatoform disorders
2.2
7.0
60
286
K03.66
ICD-10 Finland
Tooth plaque
2.0
6.9
77
404
J01DA01
ATC
[U] cefalexin
1.4
6.9
587
4940
Z01.9
ICD-10 Finland
Special examination, unspecified
2.3
6.9
50
222
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
6.9
87
477
J45.8
ICD-10 Finland
Mixed asthma
3.2
6.9
26
82
SPAT1260
SPAT
Consultation of another employee
1.7
6.9
140
884
K60.2
ICD-10 Finland
Anal fissure, unspecified
3.3
6.9
25
77
G04CA02
ATC
tamsulosin; oral
1.5
6.9
242
1736
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.8
6.8
97
552
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.1
6.8
18
44
D07AC13
ATC
mometasone; topical
1.5
6.8
257
1868
AB5CT
NOMESCO Finland
Blockage of nerv root with CT guidance
6.7
6.8
16
24
R39.1
ICD-10 Finland
Other difficulties with micturition
2.5
6.8
40
161
E29.8
ICD-10 Finland
Other testicular dysfunction
11.0
6.8
12
11
EB1VA, ,
NOMESCO Finland
1.7
6.8
130
807
SFA30
NOMESCO Finland
Three-surface restoration
1.4
6.8
445
3583
A10BG03
ATC
pioglitazone; oral
2.9
6.8
30
104
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
6.8
161
1057
R1250
NOMESCO Finland
Evaluation of functional capability
3.2
6.7
26
83
K03.2
ICD-10 Finland
Erosion of teeth
3.5
6.7
22
63
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.2
6.7
55
257
R05
ICPC
Cough
1.6
6.7
182
1232
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
7.2
6.7
15
21
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.0
6.7
28
94
R06AX22
ATC
ebastine; oral
1.6
6.7
148
955
A10BK03
ATC
empagliflozin; oral
1.8
6.7
101
587
R35
ICD-10 Finland
Polyuria
2.1
6.6
65
326
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.7
6.6
134
844
M01AC01
ATC
piroxicam; systemic, rectal
1.8
6.6
103
603
L02BA01
ATC
tamoxifen; oral
5.9
6.6
17
29
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
6.6
1002
9354
M03BX01
ATC
baclofen; systemic
3.2
6.6
25
79
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.5
6.6
214
1508
H81
ICPC
Excessive ear wax
1.6
6.6
142
910
AA400
NOMESCO Finland
Electroconvulsive therapy
4.2
6.6
17
41
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
4.2
6.6
17
41
F52.2
ICD-10 Finland
Failure of genital response
2.3
6.5
49
221
S55
ICPC
Skin, Local injection/infiltration
6.9
6.5
15
22
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
6.5
89
501
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
6.5
110
660
ZYC01
NOMESCO Finland
Remote contact by phone
2.0
6.5
71
371
A06AC51
ATC
ispaghula, combinations; oral
2.5
6.5
38
153
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
6.5
198
1377
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.5
6.5
21
60
A10BX07
ATC
[U] liraglutide
4.0
6.5
18
46
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
6.5
46
203
S10
ICPC
Boil/carbuncle
2.1
6.4
63
316
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
3.2
6.4
24
75
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.4
6.4
301
2279
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
6.4
136
867
R06AE09
ATC
levocetirizine; oral
1.7
6.4
135
859
-55
ICPC
Local injection/infiltration
7.4
6.4
14
19
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
6.4
88
496
J01MA12
ATC
levofloxacin; systemic
1.6
6.4
157
1038
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
6.4
220
1568
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.7
6.4
110
664
M01AB01
ATC
indometacin; systemic, rectal
2.1
6.3
62
311
J01FA06
ATC
roxithromycin; oral
1.4
6.3
337
2611
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.2
6.3
24
76
G02CB01
ATC
bromocriptine; systemic
11.1
6.3
11
10
N05AH03
ATC
olanzapine; systemic
1.8
6.3
90
514
L12
ICPC
Hand/finger symptom/complaint
1.6
6.3
136
872
IFA37
NOMESCO Finland
Ketamine treatment
18.1
6.3
9
5
E23.6
ICD-10 Finland
Other disorders of pituitary gland
+∞
6.3
6
*
M821, E2304,
ICD-10 Finland
+∞
6.3
6
*
XQ800
NOMESCO Finland
Prick test
2.1
6.2
61
306
R04.0
ICD-10 Finland
Epistaxis
2.0
6.2
62
313
H53.2
ICD-10 Finland
Diplopia
2.6
6.2
35
138
A10BK01
ATC
dapagliflozin; oral
1.9
6.2
78
427
XG405
NOMESCO Finland
Education on PEF monitoring
3.7
6.2
19
52
R52.9
ICD-10 Finland
Pain, unspecified
1.8
6.2
90
516
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
6.2
318
2445
M01AB55
ATC
diclofenac, combinations; oral
2.4
6.2
41
175
SPAT1211
SPAT
Application of soft bandage
2.0
6.2
70
370
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
6.2
73
392
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
6.2
125
788
NBG10
NOMESCO Finland
Acromioplastia
3.3
6.2
22
67
SGA01
NOMESCO Finland
Emergency treatment
1.5
6.1
200
1411
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
12.6
6.1
10
8
R94.7
ICD-10 Finland
Abnormal results of other endocrine function studies
12.6
6.1
10
8
M43.1
ICD-10 Finland
Spondylolisthesis
2.5
6.1
35
140
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
6.1
71
380
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.8
6.1
90
520
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.9
6.0
73
395
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
6.0
203
1440
N06AA04
ATC
clomipramine; systemic
3.4
6.0
21
63
N06AX17
ATC
milnacipran; oral
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
643
574
25.01
307.65
3.5
1.8
175.64
221.34
pmol/l
11.93
629
550
467
313
24.91
307.65
2.6
1.5
283.17
252.12
mu/l
0.92
453
294
942
1618
31.63
307.65
6.9
2.2
11.09
14.51
nmol/l
31.95
894
1505
357
84
61.97
307.65
1.9
2.3
18.51
20.87
nmol/l
1.30
329
79
652
399
37.80
307.65
2.2
1.4
3.53
5.14
u/l
4.38
506
334
706
756
23.63
307.65
3.6
1.8
26.97
36.20
nmol/l
22.28
669
735
628
740
18.08
307.65
2.9
2.2
346.87
362.96
nmol/l
1.15
582
690
265
196
17.41
295.05
2.0
1.4
5.55
12.86
iu/l
6.33
213
162
131
61
24.19
179.21
1.4
1.4
4.39
12.51
u/l
2.80
86
52
136
73
21.07
175.13
2.0
1.7
0.13
0.27
nmol/l
1.07
107
57
90
20
48.85
153.85
1.5
1.6
—
—
—
0
0
924
4907
6.09
134.11
4.8
3.5
1.19
1.76
ug/l
9.38
858
4524
996
5797
7.58
124.91
5.0
3.0
14.52
14.74
pmol/l
1.89
940
5334
1042
7448
6.87
74.05
5.8
3.6
1.80
2.01
mu/l
0.69
985
6945
162
371
4.94
67.19
2.2
3.5
4.50
4.72
pmol/l
1.62
138
341
124
227
6.02
65.98
1.7
1.4
141.24
214.39
pmol/l
1.06
124
227
541
2824
2.77
60.48
2.8
2.3
75.19
70.67
nmol/l
3.22
484
2616
624
3537
2.73
58.70
6.4
8.0
1.21
1.20
mmol/l
1.46
503
3075
544
3025
2.55
51.05
3.0
2.7
156.80
184.04
ug/l
1.51
517
2857
645
3887
2.56
50.91
3.9
3.2
22.51
20.98
%
1.26
229
1415
887
6346
2.92
47.50
7.7
7.9
73.20
77.02
u/l
1.12
850
6101
851
5986
2.77
46.63
4.1
3.7
7.48
8.86
mm/h
3.15
797
5647
545
3200
2.37
43.24
6.1
7.2
1.21
1.20
mmol/l
1.62
496
2988
84
159
5.63
42.84
1.2
1.3
51.51
40.91
u/l
0.10
71
139
72
127
5.99
39.51
1.1
1.1
—
—
—
0
0
219
865
2.90
39.47
4.7
4.0
27.93
28.68
%
0.41
164
645
1019
8187
3.76
38.65
6.9
4.9
40.05
39.38
mmol/mol
1.42
965
7797
258
1139
2.64
37.35
2.4
2.7
16.59
14.42
umol/l
4.33
245
1078
493
2907
2.24
37.14
3.0
2.5
0.54
0.66
ug/l
4.37
272
1551
461
2656
2.25
36.64
2.0
1.8
100.64
95.40
pmol/l
1.74
254
1545
1067
8980
5.13
34.70
17.9
13.9
139.66
139.69
mmol/l
0.20
1053
8780
1070
9033
5.30
34.44
18.0
14.0
4.00
3.99
mmol/l
0.21
1052
8823
629
4170
2.16
34.37
5.8
7.0
12.32
12.67
umol/l
0.15
598
4019
232
1025
2.59
33.18
2.4
2.7
26.62
25.45
%
0.56
198
917
239
1081
2.54
32.49
2.4
2.6
2.50
2.33
g/l
5.65
229
1018
690
4816
2.13
32.03
5.2
5.3
6.73
6.78
mmol/l
0.20
656
4559
1020
8483
3.31
30.62
5.3
3.8
6.04
5.98
mmol/l
0.75
959
7935
513
3250
2.07
30.38
4.6
6.0
37.54
36.73
g/l
2.80
486
3079
1024
8578
3.30
29.47
14.0
11.1
87.63
90.41
ml/min/173m2
4.39
906
7154
142
518
2.99
29.10
2.5
3.7
1.26
1.51
mmol/l
0.51
116
391
146
548
2.91
28.40
2.6
3.6
5.27
5.16
kpa
0.94
140
528
432
2618
2.06
28.40
6.3
3.5
10.08
9.35
mmol/l
1.76
365
2302
107
349
3.28
26.45
2.7
4.2
24.93
24.86
mmol/l
0.12
100
331
122
435
3.03
25.94
2.1
2.0
38.31
38.93
u/l
0.12
117
398
140
539
2.83
25.90
4.4
4.4
1.22
1.23
mmol/l
0.94
125
488
373
2223
2.02
25.03
2.6
3.5
2.34
2.35
mmol/l
0.93
323
2032
385
2344
1.98
24.14
2.4
2.3
204.12
393.06
u/l
1.96
363
2234
213
1041
2.29
23.75
1.9
1.6
1220.66
1139.06
nmol/l
0.70
165
832
113
407
2.98
23.56
1.2
1.2
59.80
124.18
iu/ml
1.69
35
133
467
3055
1.91
23.49
3.4
3.1
46.56
48.09
ng/l
0.03
334
1935
517
3516
1.88
22.87
12.2
11.7
1.16
1.21
inr
0.79
188
1061
256
1371
2.12
22.64
1.5
1.6
76682056.50
12960284.47
pmol/l
0.58
223
1196
410
2614
1.90
21.97
2.5
2.8
52.94
61.80
u/l
3.20
374
2483
186
889
2.31
21.73
7.4
6.2
—
—
—
0
0
1032
8997
2.91
21.46
15.6
12.5
20.43
24.17
mg/l
3.37
867
6997
1050
9239
3.24
21.45
5.7
4.0
1.17
1.29
mmol/l
21.69
1005
8777
1058
9360
3.43
21.20
5.9
4.3
2.78
2.90
mmol/l
4.93
1013
8876
1094
9898
5.90
21.07
12.7
9.5
38.47
34.04
u/l
3.86
1073
9659
576
4128
1.82
20.86
6.1
6.7
56.24
56.55
%
0.28
549
3958
1026
8951
2.78
20.68
5.2
3.7
1.72
1.47
mmol/l
12.14
983
8472
581
4191
1.80
20.44
6.6
6.8
28.92
28.47
%
0.49
553
4014
1050
9284
3.15
20.36
5.7
4.0
4.51
4.70
mmol/l
8.14
1013
8838
273
1563
1.99
19.83
2.2
2.1
3.18
2.83
mg/l
1.59
238
1363
647
4845
1.80
19.81
8.1
10.3
4.21
4.12
e9/l
0.43
595
4259
371
2353
1.86
19.77
4.0
4.0
6.73
10.25
mg/mmol
0.82
254
1648
357
2238
1.87
19.73
3.3
3.4
239.05
315.79
mg/l
0.14
242
1580
461
3152
1.79
19.02
3.4
3.8
38.46
35.68
u/l
0.37
443
2993
1109
10482
8.20
18.60
25.4
17.7
44.08
43.09
%
1.34
1076
9955
1109
10484
8.18
18.41
25.4
17.5
241.57
242.51
e9/l
0.20
1099
10258
1109
10501
7.97
17.91
25.4
17.4
4.97
4.78
e12/l
23.22
1099
10262
1109
10504
7.93
17.74
25.6
17.5
149.40
144.87
g/l
17.02
1103
10392
1109
10502
7.95
17.73
25.4
17.5
6.86
6.64
e9/l
3.45
1098
10261
245
1405
1.95
17.47
1.6
1.5
18.77
19.04
nmol/l
0.13
215
1248
154
749
2.22
17.05
2.6
2.4
10.54
10.70
g/l
0.17
111
683
857
7158
1.84
16.42
4.2
3.3
52.85
54.43
u/l
0.28
819
6866
292
1816
1.82
16.03
1.4
1.3
1.69
2.00
u/ml
0.19
102
522
597
4531
1.68
15.95
3.7
3.4
13.57
93.44
e6/l
—
7
57
291
1819
1.81
15.66
2.6
3.0
544.35
1067.16
ng/l
2.78
213
1488
46
125
3.80
14.99
2.0
2.1
5.54
5.85
mmol/24h
0.23
39
117
122
575
2.26
14.51
2.7
2.3
12.42
21.44
au/ml
0.63
15
55
511
3840
1.61
13.33
4.6
4.1
0.00
0.00
estimate
-0.00
124
726
513
3860
1.61
13.30
3.3
2.9
0.01
0.00
estimate
0.28
127
740
514
3870
1.61
13.29
3.3
3.0
0.00
0.00
estimate
0.50
109
659
329
2257
1.65
12.19
1.8
1.7
1.81
1.59
mmol/l
2.33
282
1972
422
3078
1.60
12.16
3.4
2.9
—
—
—
0
0
296
1980
1.67
12.08
3.2
3.3
0.00
0.01
estimate
0.96
119
677
342
2378
1.63
11.97
2.6
2.6
369.61
3884.69
umol/l
4.58
305
2195
188
1114
1.83
11.74
2.2
2.8
112.79
168.78
ug/g
2.37
155
948
52
189
2.84
10.67
1.2
1.2
3.87
3.78
mmol/l
0.20
46
176
181
1091
1.79
10.63
6.4
7.7
1.01
1.02
mmol/l
0.33
174
1037
889
7844
1.65
10.21
18.2
15.0
15.17
14.85
%
0.22
884
7714
65
274
2.46
9.96
1.8
2.1
—
—
—
0
0
275
1887
1.61
9.88
2.0
1.9
0.61
1.08
mg/l
6.95
208
1370
62
258
2.49
9.77
1.5
1.8
—
—
—
0
0
256
1736
1.62
9.62
1.8
1.5
2.54
2.57
g/l
0.10
184
1202
18
18
10.14
9.53
1.8
1.4
74.56
92.39
nmol/24h
0.45
18
18
114
620
1.93
9.23
3.2
3.4
4.73
4.76
kpa
0.05
106
601
133
762
1.85
9.18
3.6
4.3
6.01
5.90
kpa
0.65
125
744
29
82
3.60
8.99
3.7
2.6
36957.62
43551.22
ug/l
1.34
29
82
131
755
1.83
8.87
3.7
4.3
2.04
2.05
mmol/l
0.01
110
625
87
437
2.07
8.80
3.7
5.4
99.70
89.36
ng/l
0.25
74
402
173
1091
1.69
8.57
2.5
3.4
2.41
2.43
mmol/l
1.84
157
966
74
353
2.17
8.55
3.2
3.9
25.17
25.08
mmol/l
0.09
69
342
449
3522
1.46
8.36
2.6
2.6
—
—
—
0
0
128
747
1.81
8.31
2.4
3.0
1.78
1.81
%
0.15
116
692
98
534
1.92
7.89
2.9
2.7
68.55
67.40
g/l
0.88
91
507
19
45
4.28
7.49
1.1
1.2
216.53
216.33
mmol/24h
0.00
19
45
90
486
1.93
7.45
3.0
3.4
142.31
135.06
g/l
1.69
85
478
271
1970
1.50
7.24
2.2
2.0
1.41
1.49
%
1.43
231
1789
184
1230
1.59
7.19
2.1
2.1
—
—
—
0
0
222
1555
1.53
7.05
2.6
2.5
1.98
2.96
e6/l
3.10
202
1413
65
324
2.07
6.75
2.4
3.4
1.18
1.40
mg/l
1.52
58
310
74
387
1.98
6.74
1.4
1.8
4.33
4.57
mg/l
0.08
53
281
45
193
2.39
6.71
1.3
1.3
47.94
20.15
e6/l
0.47
35
143
45
193
2.39
6.71
1.4
1.3
878.59
1976.83
e6/l
0.43
39
149
308
2330
1.44
6.64
3.6
3.1
33.42
122.15
e6/l
0.91
250
1798
11
9
12.33
6.59
1.5
1.7
1.65
1.49
%
—
11
9
195
1352
1.54
6.46
2.1
2.2
—
—
—
0
0
128
804
1.67
6.40
6.9
9.6
8.67
8.53
mmol/l
0.09
119
775
19
51
3.77
6.38
2.8
4.0
—
—
—
0
0
182
1252
1.54
6.24
1.3
1.2
14.93
28.99
iu/ml
2.57
41
372
245
1793
1.47
6.23
2.4
2.5
—
—
—
0
0
40
171
2.39
6.04
2.7
2.5
17.30
17.22
%
0.03
20
94
93
546
1.77
5.94
1.6
1.3
129.73
348.07
u/ml
2.14
84
506
56
278
2.07
5.91
1.2
1.2
0.28
0.97
u/ml
—
6
22
124
796
1.63
5.70
2.6
2.5
0.23
0.23
g/l
0.13
119
738
279
2128
1.41
5.62
3.5
3.1
0.34
0.37
e6/l
0.09
224
1612
167
1154
1.53
5.59
2.2
1.9
—
—
—
0
0
137
910
1.58
5.47
5.5
10.1
1.23
0.97
mmol/l
0.42
114
734
58
304
1.96
5.30
1.9
1.7
—
—
—
0
0
164
1142
1.51
5.29
1.3
1.2
5.08
8.86
u/ml
0.42
70
512
15
32
4.74
5.00
3.0
2.9
—
—
—
0
0
20
66
3.07
4.96
1.1
1.6
—
—
—
0
0
78
464
1.73
4.79
1.5
1.4
—
—
—
0
0
87
540
1.66
4.59
5.4
9.7
24.93
24.91
mmol/l
0.01
87
535
221
1673
1.40
4.57
3.1
3.1
1.02
1.02
kg/l
0.55
27
217
72
427
1.73
4.49
1.1
1.1
—
—
—
0
0
32
143
2.27
4.44
2.6
2.4
—
—
—
0
0
129
893
1.50
4.28
5.2
4.5
217.96
237.81
u/l
2.50
123
856
12
25
4.84
4.19
2.8
2.0
67.25
48.82
ug/l
0.40
12
25
42
215
1.99
4.16
1.5
1.5
296.58
261.76
ug/g
0.48
26
124
22
85
2.62
4.15
1.1
1.0
—
—
—
0
0
230
1779
1.37
4.15
1.6
1.5
—
—
—
0
0
19
68
2.83
4.13
1.9
2.0
—
—
—
0
0
17
57
3.01
4.13
1.2
1.1
1.10
1.02
u/l
—
9
32
36
175
2.09
4.09
1.3
1.1
—
—
—
0
0
182
1369
1.39
3.89
4.2
4.2
0.83
0.82
mmol/l
0.76
169
1306
26
113
2.33
3.87
1.1
1.1
—
—
—
0
0
10
21
4.79
3.56
1.1
1.1
—
—
—
0
0
19
75
2.56
3.47
1.9
1.1
—
—
—
0
0
751
6898
1.27
3.44
3.1
3.1
—
—
—
0
0
33
170
1.97
3.26
1.5
1.8
—
—
—
0
0
21
90
2.36
3.26
1.6
1.9
—
—
—
0
0
13
43
3.05
3.25
1.1
1.2
—
63.80
%
—
0
5
9
20
4.53
3.11
1.0
1.2
-0.70
1.41
mmol/l
—
9
20
35
188
1.89
3.08
1.1
1.1
35.74
87.68
iu/ml
—
8
53
78
522
1.53
3.08
1.9
1.7
—
—
—
0
0
22
99
2.25
3.07
1.8
2.3
—
—
—
0
0
31
160
1.96
3.06
1.2
1.5
—
—
—
0
0
13
41
3.20
3.06
1.5
1.6
—
—
—
0
0
25
119
2.13
3.06
1.3
1.5
1.21
1.45
promille
0.41
19
96
22
100
2.22
3.01
1.8
1.7
—
—
—
0
0
22
100
2.22
3.01
1.8
1.7
—
—
—
0
0
45
265
1.73
2.96
1.3
1.3
—
—
—
0
0
8
17
4.73
2.92
1.0
1.3
—
—
—
0
0
18
76
2.39
2.90
2.1
1.9
13.50
13.61
%
0.02
18
76
33
178
1.88
2.89
3.3
3.7
4.20
3.89
e9/l
0.42
33
178
20
89
2.27
2.88
1.8
2.4
—
—
—
0
0
35
193
1.84
2.87
2.7
2.2
—
—
—
0
0
38
216
1.79
2.83
1.3
1.6
—
—
—
0
0
24
117
2.07
2.78
2.6
1.9
—
—
—
0
0
33
181
1.85
2.76
3.3
3.7
246.30
3412.50
u/l
—
6
55
35
196
1.81
2.74
2.6
2.2
—
—
—
0
0
24
118
2.06
2.73
1.1
1.1
—
—
—
0
0
16
66
2.44
2.71
1.2
1.1
—
—
—
0
0
33
183
1.83
2.67
3.4
4.1
57.73
55.33
%
0.75
33
183
21
99
2.14
2.66
1.8
1.7
—
—
—
0
0
21
99
2.14
2.66
1.8
1.7
—
—
—
0
0
11
35
3.16
2.64
1.6
1.9
—
—
—
0
0
39
229
1.73
2.62
4.3
1.9
—
—
—
0
0
19
87
2.20
2.58
1.1
1.0
—
—
—
0
0
12
42
2.88
2.55
1.2
2.7
18.36
609.23
ug/l
0.50
12
36
35
201
1.77
2.54
1.5
1.5
—
—
—
0
0
21
101
2.10
2.54
1.8
1.7
—
—
—
0
0
21
101
2.10
2.54
1.8
1.7
—
—
—
0
0
105
779
1.38
2.47
6.4
11.3
137.11
128.08
g/l
3.22
105
757
30
166
1.83
2.46
1.6
1.6
—
—
—
0
0
40
243
1.67
2.40
2.0
1.8
—
—
—
0
0
106
793
1.37
2.38
4.0
3.1
—
—
—
0
0
21
104
2.04
2.37
1.0
1.1
—
—
—
0
0
31
177
1.77
2.32
1.6
1.5
—
—
—
0
0
36
215
1.70
2.31
1.2
1.4
—
—
—
0
0
9
28
3.23
2.31
1.0
1.0
—
—
—
0
0
12
47
2.57
2.27
1.0
1.1
—
—
—
0
0
42
264
1.61
2.23
2.2
3.2
—
—
—
0
0
33
195
1.71
2.21
5.0
2.1
0.30
0.94
g/l
1.22
27
180
37
228
1.64
2.13
2.1
2.2
266.59
120.75
ug/min
0.30
24
136
6
15
4.02
2.04
1.0
1.1
—
—
—
0
0
8
26
3.09
2.01
1.0
1.3
—
—
—
0
0
24
133
1.82
2.00
2.4
2.3
—
—
—
0
0
24
133
1.82
2.00
2.4
2.3
—
—
—
0
0
29
171
1.71
1.98
3.0
2.3
138.24
136.50
g/l
0.11
21
125
16
77
2.09
1.97
1.4
4.9
—
—
—
0
0
28
164
1.73
1.96
1.5
1.2
—
3.11
—
0
14
5
11
4.56
1.94
1.2
1.1
—
—
—
0
0
9
33
2.74
1.93
2.6
3.2
—
—
—
0
0
9
33
2.74
1.93
2.6
3.2
—
—
—
0
0
9
33
2.74
1.93
2.6
3.2
—
—
—
0
0
14
65
2.17
1.88
1.1
1.1
—
—
—
0
0
18
94
1.93
1.80
3.0
2.3
—
—
—
0
0
9
35
2.58
1.80
1.7
1.6
12.96
15.21
umol/l
—
9
35
7
169
0.41
1.78
1.3
1.6
—
—
—
0
0
84
638
1.34
1.77
2.4
2.4
78.68
73.68
ml/min/173m2
0.54
37
234
15
74
2.04
1.75
2.1
2.2
—
—
—
0
0
15
74
2.04
1.75
2.1
2.2
—
—
—
0
0
15
74
2.04
1.75
2.1
2.2
—
—
—
0
0
12
54
2.24
1.74
1.7
1.4
0.38
0.87
u/ml
—
5
32
5
13
3.86
1.71
1.0
1.4
—
—
—
0
0
30
189
1.60
1.64
6.7
2.9
29.31
36.37
mg/l
0.41
24
143
30
189
1.60
1.64
6.7
2.9
31.73
76.86
mg/l
0.69
23
142
150
1242
1.24
1.64
3.8
2.9
1.31
0.62
e6/l
0.54
94
669
5
14
3.58
1.61
1.0
1.3
—
—
—
0
0
16
84
1.92
1.60
1.6
2.7
33.69
33.73
pg
0.02
16
84
8
32
2.51
1.60
2.3
2.1
26.75
27.97
%
—
8
32
6
21
2.87
1.50
1.0
1.8
—
—
—
0
0
15
79
1.91
1.50
1.7
1.5
77.93
80.25
umol/l
0.28
15
79
10
45
2.23
1.46
1.0
1.0
176.30
209.00
ng/l
—
10
31
10
45
2.23
1.46
1.0
1.0
21.00
25.69
ng/l
—
10
28
10
45
2.23
1.46
1.0
1.0
965.50
930.33
ng/l
—
10
30
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
52
2.13
1.44
1.0
1.2
—
—
—
0
0
19
110
1.74
1.43
1.2
1.2
—
—
—
0
0
9
39
2.32
1.43
2.6
3.0
—
—
—
0
0
9
39
2.32
1.43
2.6
3.0
—
—
—
0
0
18
103
1.76
1.41
1.2
1.3
—
—
—
0
0
14
74
1.90
1.39
2.4
2.2
852.63
650.53
ml
—
8
47
9
42
2.15
1.34
1.7
1.4
—
—
—
0
0
9
42
2.15
1.34
1.7
1.4
—
—
—
0
0
34
236
1.45
1.26
1.4
2.2
1.03
0.87
nmol/l
0.66
28
213
5
19
2.64
1.21
1.0
2.0
—
—
—
0
0
12
64
1.88
1.18
1.4
1.3
—
—
—
0
0
31
215
1.45
1.17
1.3
1.1
4.72
2.18
u/ml
0.40
19
112
22
142
1.56
1.15
1.0
1.1
8.62
2.07
u/ml
0.94
12
70
13
222
0.58
1.15
1.4
1.4
—
—
—
0
0
12
65
1.86
1.13
1.4
1.3
—
—
—
0
0
97
802
1.23
1.12
2.2
1.8
—
—
—
0
0
28
193
1.46
1.10
1.1
1.1
4.43
7.76
u/ml
0.79
14
104
35
252
1.40
1.09
1.2
1.1
—
—
—
0
0
122
1036
1.20
1.09
2.7
3.2
6.97
9.41
umol/l
1.07
111
919
5
21
2.39
1.09
1.2
1.0
54.94
58.07
u/ml
—
5
21
8
41
1.96
1.09
1.8
1.4
—
—
—
0
0
8
41
1.96
1.09
1.8
1.4
—
—
—
0
0
54
418
1.31
1.08
1.7
1.6
—
—
—
0
0
14
82
1.72
1.05
2.1
3.0
—
—
—
0
0
11
60
1.84
1.03
1.7
1.4
11.50
10.12
mmol/l
0.28
11
60
28
196
1.44
1.03
1.8
1.3
—
—
—
0
0
152
1324
1.17
1.02
3.5
2.8
0.51
0.83
e6/l
1.39
95
744
18
116
1.56
0.97
2.2
1.7
—
—
—
0
0
10
54
1.86
0.96
3.0
1.9
—
—
—
0
0
7
37
1.90
0.94
1.0
1.1
—
—
—
0
0
97
820
1.20
0.93
2.3
1.8
—
—
—
0
0
13
78
1.67
0.91
1.2
1.3
8609.83
58673.77
e6/l
—
6
61
49
386
1.28
0.89
2.1
2.7
—
—
—
0
0
58
468
1.25
0.87
2.1
2.6
—
—
—
0
0
26
186
1.41
0.87
1.5
1.6
13752.43
12919.40
e6/l
0.05
21
141
15
95
1.59
0.87
2.3
2.0
—
—
—
0
0
15
95
1.59
0.87
2.3
2.0
—
—
—
0
0
11
64
1.73
0.86
3.0
1.9
—
—
—
0
0
8
45
1.78
0.84
1.1
2.1
177.75
210.33
u/l
—
8
45
8
45
1.78
0.84
1.3
1.2
—
—
—
0
0
18
122
1.48
0.80
2.8
1.9
—
—
—
0
0
32
242
1.33
0.79
1.0
1.1
—
—
—
0
0
8
48
1.67
0.79
3.5
2.0
—
—
—
0
0
8
48
1.67
0.79
1.0
1.1
189.96
268.02
iu/ml
—
8
48
8
48
1.67
0.79
3.5
2.0
—
—
—
0
0
18
123
1.47
0.78
1.2
1.1
—
—
—
0
0
6
34
1.77
0.76
1.5
1.2
—
—
—
0
0
32
245
1.32
0.74
1.0
1.1
—
—
—
0
0
34
263
1.30
0.73
1.3
1.5
—
14.69
—
0
7
16
108
1.49
0.73
1.1
1.1
—
—
—
0
0
5
26
1.93
0.70
1.0
1.0
—
—
—
0
0
9
58
1.56
0.70
1.1
1.2
—
—
—
0
0
21
152
1.39
0.69
4.1
2.8
20.70
23.84
mg/l
—
10
92
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
172
1562
1.12
0.67
3.7
3.5
1557.91
725.55
ng/l
0.42
113
1152
5
28
1.79
0.66
1.6
1.2
—
—
—
0
0
7
44
1.59
0.65
1.0
1.2
—
—
—
0
0
5
29
1.73
0.64
3.2
4.9
—
—
—
0
0
18
129
1.40
0.63
2.4
1.7
—
—
—
0
0
8
49
1.64
0.62
1.3
1.4
—
—
—
0
0
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
19
139
1.37
0.60
1.1
1.1
—
—
—
0
0
53
445
1.20
0.60
1.2
1.3
—
—
—
0
0
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
16
116
1.38
0.54
1.3
1.6
—
—
—
0
0
60
516
1.17
0.54
2.4
2.9
126.67
145.34
ng/l
0.15
45
446
6
39
1.54
0.53
1.3
2.1
—
—
—
0
0
6
39
1.54
0.53
1.3
2.1
—
—
—
0
0
16
117
1.37
0.52
2.3
2.5
—
—
—
0
0
95
849
1.13
0.51
2.8
3.0
29.70
94.97
u/l
0.67
83
776
24
188
1.28
0.51
1.1
1.1
4.37
2.18
u/ml
—
10
94
30
243
1.24
0.50
1.4
1.6
108.93
114.55
u/ml
—
10
48
7
45
1.56
0.49
1.6
1.5
46491.43
18522.27
e6/l
—
7
30
6
95
0.63
0.42
1.8
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
3.2
—
116.71
—
0
17
19
151
1.26
0.38
2.8
1.9
—
—
—
0
0
33
285
1.16
0.32
1.2
1.3
117.44
211.14
miu/ml
—
9
131
75
686
1.10
0.31
1.9
2.2
4.63
10.09
ug/l
3.61
66
627
11
85
1.30
0.28
1.6
1.9
—
—
—
0
0
17
141
1.21
0.26
1.5
1.3
—
—
—
0
0
17
141
1.21
0.26
1.5
1.3
—
—
—
0
0
9
72
1.25
0.25
3.0
2.3
—
—
—
0
0
9
73
1.23
0.25
1.1
1.3
1.41
1.47
g/l
—
9
73
9
77
1.17
0.24
4.1
3.1
—
—
—
0
0
5
40
1.25
0.22
2.8
3.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
6.0
—
510.25
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
249
1.13
0.20
5.8
3.0
0.32
0.31
u/ml
0.10
15
136
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
6
49
1.23
0.20
1.2
1.0
1056.83
1333.67
miu/ml
—
6
49
139
1332
1.05
0.19
1.8
1.7
—
—
—
0
0
37
338
1.10
0.18
1.5
1.6
0.02
0.37
iu/ml
—
8
67
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
57
609
0.93
0.17
3.0
5.2
43.11
19.61
ug/l
0.25
43
500
31
282
1.10
0.17
1.3
1.2
—
—
—
0
0
30
329
0.91
0.16
3.4
2.5
93.37
92.63
%
0.08
30
322
9
83
1.08
0.14
1.1
1.5
1.01
1.04
g/l
—
9
83
17
188
0.90
0.11
9.2
10.2
105.65
105.21
mmol/l
0.19
17
167
10
86
1.16
0.11
3.2
4.5
—
—
—
0
0
20
184
1.09
0.09
1.1
1.1
—
—
—
0
0
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
29
273
1.06
0.08
1.3
1.2
260.06
251.50
u/ml
0.06
18
170
7
85
0.82
0.07
2.0
1.8
—
—
—
0
0
45
434
1.04
0.06
1.5
1.4
—
—
—
0
0
18
168
1.07
0.06
1.4
1.3
6.78
4.21
u/ml
—
9
80
11
104
1.06
0.01
1.0
1.2
—
—
—
0
0
15
156
0.96
0.00
1.1
1.2
—
—
—
0
0
15
154
0.97
0.00
1.2
1.1
—
—
—
0
0
17
174
0.98
0.00
1.4
1.3
11.83
6.55
u/ml
—
6
60
18
177
1.02
0.00
1.1
1.1
112.72
112.32
%
0.02
18
165
5
55
0.91
0.00
1.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
15.8
—
—
—
0
0
6
61
0.98
-0.00
1.2
1.2
—
—
—
0
0
5
52
0.96
-0.00
1.0
1.1
93.20
103.56
%
—
5
43
18
180
1.00
-0.00
3.4
4.3
3.06
134.50
u/ml
0.81
18
175
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
61
0.98
-0.00
1.2
1.2
—
—
—
0
0
6
60
1.00
-0.00
1.2
1.2
—
—
—
0
0
6
60
1.00
-0.00
1.2
1.2
—
—
—
0
0
6
61
0.98
-0.00
1.2
1.2
—
—
—
0
0
49
490
1.00
-0.00
1.9
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
8.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
9.00
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
9.51
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: E4_HYPOGONADOTROPIC_HYPOGONADISM – Hypogonadotropic hypogonadism
GWS hits: 2
This endpoint is excluded (different definition than used in FinnGen).